Cargando…

Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases

BACKGROUND: Temporal pattern discovery (TPD) is a method of signal detection using electronic healthcare databases, serving as an alternative to spontaneous reporting of adverse drug events. Here, we aimed to replicate and optimise a TPD approach previously used to assess temporal signals of statins...

Descripción completa

Detalles Bibliográficos
Autores principales: Lavallee, M., Yu, T., Evans, L., Van Hemelrijck, M., Bosco, C., Golozar, A., Asiimwe, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812213/
https://www.ncbi.nlm.nih.gov/pubmed/35115001
http://dx.doi.org/10.1186/s12911-022-01765-1
_version_ 1784644601178488832
author Lavallee, M.
Yu, T.
Evans, L.
Van Hemelrijck, M.
Bosco, C.
Golozar, A.
Asiimwe, A.
author_facet Lavallee, M.
Yu, T.
Evans, L.
Van Hemelrijck, M.
Bosco, C.
Golozar, A.
Asiimwe, A.
author_sort Lavallee, M.
collection PubMed
description BACKGROUND: Temporal pattern discovery (TPD) is a method of signal detection using electronic healthcare databases, serving as an alternative to spontaneous reporting of adverse drug events. Here, we aimed to replicate and optimise a TPD approach previously used to assess temporal signals of statins with rhabdomyolysis (in The Health Improvement Network (THIN) database) by using the OHDSI tools designed for OMOP data sources. METHODS: We used data from the Truven MarketScan US Commercial Claims and the Commercial Claims and Encounters (CCAE). Using an extension of the OHDSI ICTemporalPatternDiscovery package, we ran positive and negative controls through four analytical settings and calculated sensitivity, specificity, bias and AUC to assess performance. RESULTS: Similar to previous findings, we noted an increase in the Information Component (IC) for simvastatin and rhabdomyolysis following initial exposure and throughout the surveillance window. For example, the change in IC was 0.266 for the surveillance period of 1–30 days as compared to the control period of − 180 to − 1 days. Our modification of the existing OHDSI software allowed for faster queries and more efficient generation of chronographs. CONCLUSION: Our OMOP replication matched the we can account forwe can account for of the original THIN study, only simvastatin had a signal. The TPD method is a useful signal detection tool that provides a single statistic on temporal association and a graphical depiction of the temporal pattern of the drug outcome combination. It remains unclear if the method works well for rare adverse events, but it has been shown to be a useful risk identification tool for longitudinal observational databases. Future work should compare the performance of TPD with other pharmacoepidemiology methods and mining techniques of signal detection. In addition, it would be worth investigating the relative TPD performance characteristics using a variety of observational data sources.
format Online
Article
Text
id pubmed-8812213
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-88122132022-02-07 Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases Lavallee, M. Yu, T. Evans, L. Van Hemelrijck, M. Bosco, C. Golozar, A. Asiimwe, A. BMC Med Inform Decis Mak Research Article BACKGROUND: Temporal pattern discovery (TPD) is a method of signal detection using electronic healthcare databases, serving as an alternative to spontaneous reporting of adverse drug events. Here, we aimed to replicate and optimise a TPD approach previously used to assess temporal signals of statins with rhabdomyolysis (in The Health Improvement Network (THIN) database) by using the OHDSI tools designed for OMOP data sources. METHODS: We used data from the Truven MarketScan US Commercial Claims and the Commercial Claims and Encounters (CCAE). Using an extension of the OHDSI ICTemporalPatternDiscovery package, we ran positive and negative controls through four analytical settings and calculated sensitivity, specificity, bias and AUC to assess performance. RESULTS: Similar to previous findings, we noted an increase in the Information Component (IC) for simvastatin and rhabdomyolysis following initial exposure and throughout the surveillance window. For example, the change in IC was 0.266 for the surveillance period of 1–30 days as compared to the control period of − 180 to − 1 days. Our modification of the existing OHDSI software allowed for faster queries and more efficient generation of chronographs. CONCLUSION: Our OMOP replication matched the we can account forwe can account for of the original THIN study, only simvastatin had a signal. The TPD method is a useful signal detection tool that provides a single statistic on temporal association and a graphical depiction of the temporal pattern of the drug outcome combination. It remains unclear if the method works well for rare adverse events, but it has been shown to be a useful risk identification tool for longitudinal observational databases. Future work should compare the performance of TPD with other pharmacoepidemiology methods and mining techniques of signal detection. In addition, it would be worth investigating the relative TPD performance characteristics using a variety of observational data sources. BioMed Central 2022-02-03 /pmc/articles/PMC8812213/ /pubmed/35115001 http://dx.doi.org/10.1186/s12911-022-01765-1 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Lavallee, M.
Yu, T.
Evans, L.
Van Hemelrijck, M.
Bosco, C.
Golozar, A.
Asiimwe, A.
Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases
title Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases
title_full Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases
title_fullStr Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases
title_full_unstemmed Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases
title_short Evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in OMOP databases
title_sort evaluating the performance of temporal pattern discovery: new application using statins and rhabdomyolysis in omop databases
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8812213/
https://www.ncbi.nlm.nih.gov/pubmed/35115001
http://dx.doi.org/10.1186/s12911-022-01765-1
work_keys_str_mv AT lavalleem evaluatingtheperformanceoftemporalpatterndiscoverynewapplicationusingstatinsandrhabdomyolysisinomopdatabases
AT yut evaluatingtheperformanceoftemporalpatterndiscoverynewapplicationusingstatinsandrhabdomyolysisinomopdatabases
AT evansl evaluatingtheperformanceoftemporalpatterndiscoverynewapplicationusingstatinsandrhabdomyolysisinomopdatabases
AT vanhemelrijckm evaluatingtheperformanceoftemporalpatterndiscoverynewapplicationusingstatinsandrhabdomyolysisinomopdatabases
AT boscoc evaluatingtheperformanceoftemporalpatterndiscoverynewapplicationusingstatinsandrhabdomyolysisinomopdatabases
AT golozara evaluatingtheperformanceoftemporalpatterndiscoverynewapplicationusingstatinsandrhabdomyolysisinomopdatabases
AT asiimwea evaluatingtheperformanceoftemporalpatterndiscoverynewapplicationusingstatinsandrhabdomyolysisinomopdatabases